BMO Capital Markets Issues Positive Forecast for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) had its price objective hoisted by equities research analysts at BMO Capital Markets from $24.00 to $28.00 in a report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price objective indicates a potential upside of 29.09% from […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) had its price objective hoisted by equities research analysts at BMO Capital Markets from $24.00 to $28.00 in a report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price objective indicates a potential upside of 29.09% from […]
